Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73


Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community.

Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL, Coresh J, Levey AS, Sarnak MJ.

J Am Coll Cardiol. 2003 Jan 1;41(1):47-55.


Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study.

Ninomiya T, Kiyohara Y, Tokuda Y, Doi Y, Arima H, Harada A, Ohashi Y, Ueshima H; Japan Arteriosclerosis Longitudinal Study Group.

Circulation. 2008 Dec 16;118(25):2694-701. doi: 10.1161/CIRCULATIONAHA.108.792903.


Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study.

Sarnak MJ, Tighiouart H, Manjunath G, MacLeod B, Griffith J, Salem D, Levey AS.

J Am Coll Cardiol. 2002 Jul 3;40(1):27-33.


Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study.

Kottgen A, Russell SD, Loehr LR, Crainiceanu CM, Rosamond WD, Chang PP, Chambless LE, Coresh J.

J Am Soc Nephrol. 2007 Apr;18(4):1307-15. Epub 2007 Mar 7.


Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease.

Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, Anderson JE.

Nephrol Dial Transplant. 2006 May;21(5):1257-62. Epub 2006 Jan 18.


Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.

Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS.

Ann Intern Med. 2006 Aug 15;145(4):237-46.


Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients.

Wang AY, Lam CW, Wang M, Woo J, Chan IH, Lui SF, Sanderson JE, Li PK.

Am J Kidney Dis. 2005 Apr;45(4):715-29.


Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.

Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ.

J Am Soc Nephrol. 2004 May;15(5):1307-15.


Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.

Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT Jr, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber MA, Franklin S, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T; ALLHAT Collaborative Research Group.

Ann Intern Med. 2006 Feb 7;144(3):172-80.


Renal function predicts cardiovascular outcomes in southern Italian postmenopausal women.

Perticone F, Sciacqua A, Maio R, Perticone M, Laino I, Bruni R, Cello SD, Leone GG, Greco L, Andreozzi F, Sesti G.

Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):481-6. doi: 10.1097/HJR.0b013e32832b8d87.


Chronic kidney disease and mortality and morbidity among patients with established cardiovascular disease: a West of Ireland community-based cohort study.

Glynn LG, Reddan D, Newell J, Hinde J, Buckley B, Murphy AW.

Nephrol Dial Transplant. 2007 Sep;22(9):2586-94. Epub 2007 Apr 23.


Decreased glomerular filtration rate is a risk factor for hemorrhagic but not for ischemic stroke: the Rotterdam Study.

Bos MJ, Koudstaal PJ, Hofman A, Breteler MM.

Stroke. 2007 Dec;38(12):3127-32. Epub 2007 Oct 25.


Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.

Jones C, Roderick P, Harris S, Rogerson M.

Nephrol Dial Transplant. 2006 Aug;21(8):2133-43. Epub 2006 Apr 27.


Lipoprotein(a) and prevalent cardiovascular disease in a dialysis population: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study.

Longenecker JC, Coresh J, Marcovina SM, Powe NR, Levey AS, Giaculli F, Fink NE, Klag MJ.

Am J Kidney Dis. 2003 Jul;42(1):108-16.


Kidney disease as a risk factor for recurrent cardiovascular disease and mortality.

Weiner DE, Tighiouart H, Stark PC, Amin MG, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ.

Am J Kidney Dis. 2004 Aug;44(2):198-206.


Renal dysfunction and ischemic heart disease mortality in a hypertensive population.

Hailpern SM, Cohen HW, Alderman MH.

J Hypertens. 2005 Oct;23(10):1809-16.


Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes.

Ryu S, Chang Y, Woo HY, Lee KB, Kim SG, Kim DI, Kim WS, Suh BS, Jeong C, Yoon K.

Am J Kidney Dis. 2009 Jan;53(1):59-69. doi: 10.1053/j.ajkd.2008.07.027. Epub 2008 Oct 5. Erratum in: Am J Kidney Dis. 2009 May;53(5):913.

Items per page

Supplemental Content

Support Center